Mechanism of triptolide in the treatment of gastric cancer with diabetes through JAK2/STAT3 pathway
European Journal of Pharmacology · 2026
DOI: 10.1016/j.ejphar.2025.178404 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Weiguo Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, Stomach Neoplasms, Phenanthrenes. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Excellent Young Scientists Fund, National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Univariate and multivariate Cox analyses revealed a correlation between diabetes and the prognosis of gastric cancer patients (p < 0.05). Using bioinformatics, Serine/threonine-protein kinase pim-1 (PIM1) was identified as the core target gene of triptolide in the treatment of gastric cancer patients with diabetes. Cell Counting Kit-8 (CCK8), cell scratch and plate cloning experiments revealed that triptolide can inhibit the proliferation and migration ability of AGS and HGC-27 cells in a high-glucose environment. Western blot and flow cytometry analysis revealed that triptolide can inhibit PIM1 protein expression, reduce JAK2/STAT3 phosphorylation, and promote apoptosis in AGS and HGC-27 cells under high-glucose conditions. Diabetes is an independent prognostic risk factor for patients with gastric cancer. Triptolide reverses the malignant phenotype of gastric cancer cells induced by high glucose by targeting the PIM1-JAK2/STAT3 signalling axis, providing an experimental basis for the precise treatment of patients with gastric cancer with diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China.
- Department of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, Anhui, 230032, People's Republic of China.
- Department of Gastroenterology, Lishui Municipal Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, Zhejiang Province, People's Republic of China. Electronic address: 90707438…
- Department of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, Anhui, 230032, People's Republic of China; The First Department of Critical Care Medicine, The Second Affiliated Hospital o…
- Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China. Electronic address: zhz36@sina.com.
Förderung
- Excellent Young Scientists Fund
- National Natural Science Foundation of China
Zitieren
APA
Zhou, W., Xu, X., Zhu, H., Qian, Y., Xu, X., Huang, A. X., Hu, S., Yang, K., Yuan, B., & Zhang, Z. (2026). Mechanism of triptolide in the treatment of gastric cancer with diabetes through JAK2/STAT3 pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178404
Vancouver
Zhou W, Xu X, Zhu H, Qian Y, Xu X, Huang AX, et al. Mechanism of triptolide in the treatment of gastric cancer with diabetes through JAK2/STAT3 pathway. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2025.178404
BibTeX
@article{Zhou2026,
author = {Zhou, Weiguo and Xu, Xinjian and Zhu, Hong and Qian, Yuyang and Xu, Xin and Huang, Aolin Xiao and Hu, Shuqi and Yang, Kang and Yuan, Bin and Zhang, Zhen},
title = {Mechanism of triptolide in the treatment of gastric cancer with diabetes through JAK2/STAT3 pathway},
journal = {European Journal of Pharmacology},
year = {2026},
doi = {10.1016/j.ejphar.2025.178404}
}
EUVIMED